Sign In
Buy MRTX
$58.70
+0 (+0%)
At Close: Apr 19, 2024
AQR Capital Management LLC Has $1.76 Million Stock Holdings in Mirati Therapeutics Inc (NASDAQ:MRTX)
08:34am, Monday, 06'th Apr 2020
AQR Capital Management LLC boosted its holdings in shares of Mirati Therapeutics Inc (NASDAQ:MRTX) by 14.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the
Mirati Therapeutics Inc (NASDAQ:MRTX) Receives Consensus Rating of "Buy" from Analysts
09:38am, Sunday, 05'th Apr 2020
Mirati Therapeutics Inc (NASDAQ:MRTX) has earned an average rating of “Buy” from the nineteen ratings firms that are presently covering the stock, Marketbeat reports. Six investment analysts have
Raymond James & Associates Buys Shares of 5,090 Mirati Therapeutics Inc (NASDAQ:MRTX)
08:44am, Saturday, 04'th Apr 2020
Raymond James & Associates bought a new stake in Mirati Therapeutics Inc (NASDAQ:MRTX) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (
Cubist Systematic Strategies LLC Grows Position in Mirati Therapeutics Inc (NASDAQ:MRTX)
10:58am, Friday, 03'rd Apr 2020
Cubist Systematic Strategies LLC raised its holdings in Mirati Therapeutics Inc (NASDAQ:MRTX) by 3,781.1% during the 4th quarter, according to the company in its most recent filing with the Securities
Axa Increases Holdings in Mirati Therapeutics Inc (NASDAQ:MRTX)
08:40am, Wednesday, 01'st Apr 2020
Axa increased its stake in shares of Mirati Therapeutics Inc (NASDAQ:MRTX) by 2.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional inv
Mirati Therapeutics (NASDAQ:MRTX) Stock Price Down 6.5% After Analyst Downgrade
06:00am, Wednesday, 01'st Apr 2020
Mirati Therapeutics Inc (NASDAQ:MRTX)’s share price fell 6.5% during mid-day trading on Tuesday after Oppenheimer lowered their price target on the stock from $129.00 to $105.00. Oppenheimer current
XBI: Biotech ETF Expected To Outperform During And After The Coronavirus Pandemic
02:32pm, Tuesday, 31'st Mar 2020
S&P Biotech ETF (XBI) slumped -20% year-to-date, in-line with the S&P 500, due to the unrelenting coronavirus pandemic,. Heavy exposure to small caps contribute
JonesTrading Thinks Monopar Therapeutics Inc's Stock is Going to Recover
12:07pm, Tuesday, 31'st Mar 2020
In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Monopar Therapeutics Inc (MNPR). The company's shares closed last
JonesTrading Thinks Monopar Therapeutics Inc’s Stock is Going to Recover
12:07pm, Tuesday, 31'st Mar 2020
In a report released today,
Soumit Roy
from JonesTrading reiterated a
Buy
rating on Monopar Therapeutics Inc (
MNPR
–
Research Report
). The company’s shares closed last Monday at $7.09, close to
Amgen Inc (NASDAQ: AMGN) Q4 2019 Earnings Call Transcript | AlphaStreet
08:30am, Tuesday, 31'st Mar 2020
My name is Ian and I will be you conference facilitator today for Amgen's Fourth Quarter 2019 Financial Results Conference Call.
Mirati Therapeutics price target lowered to $105 from $129 at Oppenheimer MRTX
12:21pm, Monday, 30'th Mar 2020
Mirati Therapeutics price target lowered to $105 from $129 at Oppenheimer Oppenheimer MRTX
Oppenheimer Remains a Buy on Mirati Therapeutics (MRTX)
01:46am, Monday, 30'th Mar 2020
Oppenheimer analyst Jay Olson maintained a Buy rating on Mirati Therapeutics (MRTX) yesterday and set a price target of $105.00. The company's shares
Oppenheimer Remains a Buy on Mirati Therapeutics (MRTX)
01:46am, Monday, 30'th Mar 2020
Oppenheimer analyst
Jay Olson
maintained a
Buy
rating on Mirati Therapeutics (
MRTX
–
Research Report
) yesterday and set a price target of
$105.00
. The company’s shares closed last Friday at $76
Great West Life Assurance Co. Can Purchases New Shares in Mirati Therapeutics Inc (NASDAQ:MRTX)
10:10am, Saturday, 28'th Mar 2020
Great West Life Assurance Co. Can purchased a new position in Mirati Therapeutics Inc (NASDAQ:MRTX) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC.
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Intuitive Surgical (ISRG), Frequency Therapeutics (FREQ)
